而英克隆系统公司的抗癌药物Erbitux引起警告是由于百分之三左右的患者中存在严重并且有时甚至致命的反应。
And ImClone Systems Inc's cancer drug Erbitux carries a warning due to serious and sometimes fatal reactions in about 3 percent of patients.
而英克隆系统公司的抗癌药物Erbitux引起警告是由于百分之三左右的患者中存在严重并且有时甚至致命的反应。
And ImClone Systems Inc's cancer drug Erbitux carries a warning due to serious and sometimes fatal reactions in about 3 percent of patients.
应用推荐